コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 nge was sufficient to confer resistance to L-chicoric acid.
2 atalysis in vitro, and cross-resistance to l-chicoric acid.
3 ed neutral, nonhydrolyzable analogues of the chicoric acids.
4 dertaken to examine structural features of L-chicoric acid (3) which are important for potency agains
5 analogues, it was shown that enantiomeric D-chicoric acid (4) retains inhibitory potency against pur
10 st HIV-1- and HIV-2-infected MT-4 cells, the chicoric acids and their tetraacetylated esters exhibite
11 potent compounds were D-chicoric acid, meso-chicoric acid, bis(3,4-dihydroxydihydrocinnamoyl)-L-tart
14 y related IN inhibitor, the tetra-acetylated-chicoric acid derivative (2R,3R)-2,3-bis[[(2E)-3-[3,4-bi
15 , potent antiviral IN inhibitors such as the chicoric acids do not act upon the intended enzymatic ta
16 ted in target and cell-based assays that the chicoric acids do not significantly inhibit other target
17 e presence of increasing concentrations of L-chicoric acid, HIV-1 was completely resistant to the com
19 thoxyoxalyl-3,5-dicaffeoylquinic acid, and L-chicoric acid, inhibit HIV-1 integrase in biochemical as
20 previous biochemical studies showing that L-chicoric acid inhibits integrase and that the drug is li
22 d derivates and one digalloylderivative of L-chicoric acid (L-CA) showed improved selectivity over L-
26 id change at position 140 into the native, L-chicoric acid-sensitive virus demonstrated that this cha
27 study also examined the reported ability of chicoric acid to exert cytoprotective effects in HIV-inf
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。